CClinicalTrials.gg
CompletedNCT05727566Updated May 13, 2025

Sexual Dysfunction in Patients With Myofascial Pain Syndrome

An observational study in Sexual Dysfunction and Myofascial Pain Syndrome, sponsored by Konya Beyhekim Training and Research Hospital. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-13.

Sponsored by Konya Beyhekim Training and Research Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
90
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

This study evaluates the frequency of sexual dysfunction in women with myofascial pain syndrome and its relationship with clinical parameters.

Read the detailed description

The frequency of sexual dysfunction in reproductive-aged married women with primary myofascial pain syndrome will be evaluated in a prospective, cross-sectional survey-type study. The medical history of each participant was obtained and they underwent a detailed physical examination. Sociodemographic and clinic characteristics of all participants (age, education, marital status, employment status, family structure, income status, Body Mass Index(BMI), disease duration, number of pregnancies, sleep quality, etc.) were recorded. Pain and fatigue levels of the patients were measured by the visual pain scale (VAS), mood states by the Beck depression index (BDI), sexual function of the participants was assessed by the 0-10 Visual Analog Scale (VAS) to assess the degree of importance of sexuality (the sexuality-importance score). In addition, weekly/monthly sexual intercourse frequency was asked to all participants (patient and control groups). The questionnaires were administered to all participants in a room where they were alone with a female physician, and a suitable environment was provided for the patients to fill out the questionnaire. Patients were assured of the confidentiality of their information. Only questions that were not understood by the patient were explained without guidance.

02

Conditions studied

  • Sexual Dysfunction
  • Myofascial Pain Syndrome

Keywords

  • sexual dysfunction
  • myofascial pain sydrome
  • pain
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 90 is close to the median of 90 across 181 observational studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Konya Beyhekim Training and Research Hospital is the lead sponsor of 31 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

40 patients with primer myofascial pain syndrome and 40 healthy volunteers

Inclusion criteria

  • Myofascial pain syndrome (>3 months) was diagnosed in a female.
  • Being between the ages of 18 and 50, married, sexually active, and not menopausal
  • Volunteering to participate in the study, and being able to communicate easily.

Exclusion criteria

Exclusion Criteria:

  • a history of systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological, etc.)
  • major psychiatric illness, mental retardation
  • uncontrollable respiratory system problems
  • endocrine diseases, neurological diseases
  • previous hysterectomy or vaginal surgery, a history of sexually transmitted diseases
  • urinary or anal incontinence
  • limited motion in the upper or lower extremities
  • Fibromyalgia
  • inflammatory rheumatic diseases (such as rheumatoid arthritis, ankylosing spondylitis, etc.)
  • cervical/lumbar radiculopathy or myelopathy
  • communication problems
  • pregnancy, lactation
  • taking estrogen therapy
  • use antidepressant, anxiolytic, and antiepileptic drugs
  • chronic alcohol users
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
90 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients with primer myofascial pain sydrome

    pain for at least three months (myofascial pain) reproductive-aged married womens (18-50 years)

    Other: visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

  • Healthy controls

    Healthy control of reproductive-aged married women with compatible sociodemographic characteristics

    Other: visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

Interventions

  • Othervisual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

    visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

06

What researchers measure

Primary outcomes

  1. Sexuality-importance score

    Sexual function of the participants was assessed by the 0 (never mind)-10(very important) Visual Analog Scale (VAS) to assess the degree of importance of sexuality.

    Time frame: 11.05.2022-15.03.2023 (cross-sectional)

  2. The frequency of sexual intercourse

    Weekly/monthly sexual intercourse frequency was asked of all participants.

    Time frame: 11.05.2022-15.03.2023 (cross-sectional

Secondary outcomes

  1. Visual analog scale (VAS pain/fatigue)

    All participants were assessed in terms of pain and fatigue levels by means of a visual analogue scale of 0-10 cm (VAS).

    Time frame: 11.05.2022 - 15.03.2023 (cross-sectional)

  2. Beck depression index (BDI)

    In the assessment of depression severity, the Turkish version of the 21-item Beck Depression Inventory (BDI) was used, which is one of the most common psychometric tests used and a value of 0 to 3 is assigned for each answer to each item.

    Time frame: 11.05.2022 - 15.03.2023 (cross-sectional)

07

Study locations

1 site
  • University of Health Sciences, Konya Beyhekim Training and Research Hospital, Department of Physical Medicine and Rehabilitation
    Konya, 42060, Turkey
08

References and documents

Publications

  • Yilmaz H, Yilmaz SD, Polat HA, Salli A, Erkin G, Ugurlu H. The effects of fibromyalgia syndrome on female sexuality: a controlled study. J Sex Med. 2012 Mar;9(3):779-85. doi: 10.1111/j.1743-6109.2011.02619.x. Epub 2012 Jan 12. PubMed 22240036 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05727566
Lead sponsor
Konya Beyhekim Training and Research Hospital
Responsible party
Ramazan Yılmaz, MD (asistant prof (MD), Konya Beyhekim Training and Research Hospital) — Principal investigator
First posted
Feb 14, 2023
Start date
May 11, 2022
Primary completion
Mar 15, 2023
Completion
Apr 15, 2023
Last update
May 13, 2025

Study contacts

Ramazan Yılmaz, asist. prof
study chair · Konya Beyhekim Training and Research Hospital, Konya, Turkey

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion